Eighty-one per cent of the MSS tumours were positive for DHHC9, showing a supranuclear accumulation of DHHC9 (Figure 2G–L), while 77% of the MSI tumours were negative for DHHC9 (Figure 2M–R). Here, ZDHHC9 is linked to neoplasm.